Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) stock fell -3.52% on Wednesday to $0.74 against a previous-day closing price of $0.76. With 0.41 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.27 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $0.7764 whereas the lowest price it dropped to was $0.7001. The 52-week range on AVAH shows that it touched its highest point at $7.71 and its lowest point at $0.73 during that stretch. It currently has a 1-year price target of $2.79.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AVAH was down-trending over the past week, with a drop of -8.40%, but this was down by -51.32% over a month. Three-month performance dropped to -65.17% while six-month performance fell -75.98%. The stock lost -89.85% in the past year, while it has lost -90.07% so far this year. A look at the trailing 12-month EPS for AVAH yields -2.98 with Next year EPS estimates of 0.03. For the next quarter, that number is -0.01. This implies an EPS growth rate of -116.60% for this year and -37.50% for next year.
Float and Shares Shorts:
At present, 186.11 million AVAH shares are outstanding with a float of 174.13 million shares on hand for trading. On Oct 13, 2022, short shares totaled 2.16 million, which was 1.16% higher than short shares on Sep 14, 2022. In addition to Mr. Rodney D. Windley as the firm’s Exec. Chairman, Mr. Tony Strange serves as its CEO & Director.
Through their ownership of 92.37% of AVAH’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 8.60% of AVAH, in contrast to 3.55% held by mutual funds. Shares owned by individuals account for 12.96%. As the largest shareholder in AVAH with 4.84% of the stake, Nut Tree Capital Management LP holds 9,000,000 shares worth 9,000,000. A second-largest stockholder of AVAH, Vaughan Nelson Investment Managem, holds 5,011,476 shares, controlling over 2.70% of the firm’s shares. Littlejohn & Co. LLC is the third largest shareholder in AVAH, holding 4,150,082 shares or 2.23% stake. With a 1.39% stake in AVAH, the Bridge Builder Small/Mid Cap Valu is the largest stakeholder. A total of 2,582,477 shares are owned by the mutual fund manager. The Crown Sigma UCITS Plc – LGT Crown, which owns about 0.78% of AVAH stock, is the second-largest Mutual Fund holder. It holds 1,450,000 shares valued at 2.02 million. Vanguard Total Stock Market Index holds 0.75% of the stake in AVAH, owning 1,391,988 shares worth 1.93 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AVAH since 8 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 1 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With AVAH analysts setting a high price target of $4.00 and a low target of $1.10, the average target price over the next 12 months is $2.26. Based on these targets, AVAH could surge 440.54% to reach the target high and rise by 48.65% to reach the target low. Reaching the average price target will result in a growth of 205.41% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. AVAH will report FY 2022 earnings on 03/27/2023. For AVAH, this leads to a yearly average estimate of $0.01. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Aveanna Healthcare Holdings Inc. surprised analysts by -$0.07 when it reported -$0.03 EPS against a consensus estimate of $0.04. The surprise factor in the prior quarter was -$0.03. Based on analyst estimates, the high estimate for the next quarter is -$0.01 and the low estimate is -$0.04. The average estimate for the next quarter is thus -$0.03.
Summary of Insider Activity:
Insiders traded AVAH stock several times over the past three months with 1 Buys and 0 Sells. In these transactions, 10,000 shares were bought while 0 shares were sold. The number of buy transactions has increased to 31 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 1,877,243 while 0 shares were sold.